EP1255603A1 - Materiau de garnissage pour la separation de biomolecules - Google Patents
Materiau de garnissage pour la separation de biomoleculesInfo
- Publication number
- EP1255603A1 EP1255603A1 EP00904138A EP00904138A EP1255603A1 EP 1255603 A1 EP1255603 A1 EP 1255603A1 EP 00904138 A EP00904138 A EP 00904138A EP 00904138 A EP00904138 A EP 00904138A EP 1255603 A1 EP1255603 A1 EP 1255603A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sorbent
- affinity
- substance
- separation
- packing material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000926 separation method Methods 0.000 title claims abstract description 43
- 239000000463 material Substances 0.000 title claims description 58
- 238000012856 packing Methods 0.000 title claims description 32
- 239000002594 sorbent Substances 0.000 claims abstract description 68
- 239000003446 ligand Substances 0.000 claims abstract description 51
- 238000005859 coupling reaction Methods 0.000 claims abstract description 40
- 229920000642 polymer Polymers 0.000 claims abstract description 40
- 230000008878 coupling Effects 0.000 claims abstract description 39
- 238000010168 coupling process Methods 0.000 claims abstract description 38
- 238000001179 sorption measurement Methods 0.000 claims abstract description 27
- 238000000576 coating method Methods 0.000 claims abstract description 23
- 125000006850 spacer group Chemical group 0.000 claims abstract description 23
- 239000011248 coating agent Substances 0.000 claims abstract description 22
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 44
- 239000000126 substance Substances 0.000 claims description 30
- 229910044991 metal oxide Inorganic materials 0.000 claims description 21
- 150000004706 metal oxides Chemical class 0.000 claims description 21
- 238000004587 chromatography analysis Methods 0.000 claims description 17
- 229920002873 Polyethylenimine Polymers 0.000 claims description 13
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 11
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 9
- 230000000717 retained effect Effects 0.000 claims description 7
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims 1
- 229960005309 estradiol Drugs 0.000 description 39
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 32
- 229930182833 estradiol Natural products 0.000 description 32
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- 230000003993 interaction Effects 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 239000011715 vitamin B12 Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 18
- 239000008363 phosphate buffer Substances 0.000 description 18
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 16
- 229930003779 Vitamin B12 Natural products 0.000 description 15
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 15
- 239000000377 silicon dioxide Substances 0.000 description 15
- 235000019163 vitamin B12 Nutrition 0.000 description 15
- 230000004913 activation Effects 0.000 description 14
- 239000011521 glass Substances 0.000 description 14
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 13
- 150000001299 aldehydes Chemical class 0.000 description 13
- 239000007790 solid phase Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- -1 alumina Chemical class 0.000 description 12
- 239000012086 standard solution Substances 0.000 description 12
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 230000005526 G1 to G0 transition Effects 0.000 description 10
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 230000027455 binding Effects 0.000 description 10
- 125000000524 functional group Chemical group 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 230000000800 xenoestrogenic effect Effects 0.000 description 8
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 description 7
- 239000012491 analyte Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 108010015776 Glucose oxidase Proteins 0.000 description 6
- 239000004366 Glucose oxidase Substances 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 230000003167 anti-vitamin Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 229940116332 glucose oxidase Drugs 0.000 description 6
- 235000019420 glucose oxidase Nutrition 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 5
- KHURTEAYLZEQHD-UHFFFAOYSA-N 3-n-propylpropane-1,1,3-triamine Chemical compound CCCNCCC(N)N KHURTEAYLZEQHD-UHFFFAOYSA-N 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000004007 reversed phase HPLC Methods 0.000 description 5
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 5
- 229940014800 succinic anhydride Drugs 0.000 description 5
- 238000001323 two-dimensional chromatography Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 3
- 229960002213 alprenolol Drugs 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 125000003636 chemical group Chemical group 0.000 description 3
- 239000007771 core particle Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000013047 polymeric layer Substances 0.000 description 3
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- UYBWIEGTWASWSR-UHFFFAOYSA-N 1,3-diaminopropan-2-ol Chemical compound NCC(O)CN UYBWIEGTWASWSR-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- FUGYGGDSWSUORM-UHFFFAOYSA-N 4-hydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1 FUGYGGDSWSUORM-UHFFFAOYSA-N 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 229920000592 inorganic polymer Polymers 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000009835 non selective interaction Effects 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 125000005372 silanol group Chemical group 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 1
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 1
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- LOTYADDQWWVBDJ-UHFFFAOYSA-N 2-methyl-2-nitropropane-1,3-diol Chemical compound OCC(C)(CO)[N+]([O-])=O LOTYADDQWWVBDJ-UHFFFAOYSA-N 0.000 description 1
- SVRGUNPFMROZBU-UHFFFAOYSA-N 2-octan-3-yloxycarbonylbenzoic acid Chemical compound CCCCCC(CC)OC(=O)C1=CC=CC=C1C(O)=O SVRGUNPFMROZBU-UHFFFAOYSA-N 0.000 description 1
- BZRUULTWBBANFK-UHFFFAOYSA-N 3-N-propylpropane-1,1,3-triamine Chemical compound NC(CCNCCC)N.NC(CCNCCC)N BZRUULTWBBANFK-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010085330 Estradiol Receptors Proteins 0.000 description 1
- 102100038595 Estrogen receptor Human genes 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000016979 Other receptors Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- USNWAMPROKAEIT-UHFFFAOYSA-N [Na].C(C=C)(=O)O Chemical compound [Na].C(C=C)(=O)O USNWAMPROKAEIT-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- QYHYQHPUNPVNDV-UHFFFAOYSA-N aluminane Chemical compound C1CC[AlH]CC1 QYHYQHPUNPVNDV-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000005289 controlled pore glass Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 108091007930 cytoplasmic receptors Proteins 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002171 ethylene diamines Chemical class 0.000 description 1
- 238000004401 flow injection analysis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003688 hormone derivative Substances 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- YLJRCXSSKLWCDE-UHFFFAOYSA-N methyl ethanesulfonate Chemical compound CCS(=O)(=O)OC YLJRCXSSKLWCDE-UHFFFAOYSA-N 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- OCQZXMCGTAWGEQ-UHFFFAOYSA-N prop-2-enamide;n-[(prop-2-enoylamino)methyl]prop-2-enamide Chemical compound NC(=O)C=C.C=CC(=O)NCNC(=O)C=C OCQZXMCGTAWGEQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/284—Porous sorbents based on alumina
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
- B01J20/3282—Crosslinked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1807—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using counter-currents, e.g. fluidised beds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography
Definitions
- the invention relates to the field of separation of molecules, in particular biomolecules, from media containing said molecules .
- Biological materials comprise a great variety of molecules.
- Central molecules are nucleotides and polymers thereof, including nucleic acids (DNA and RNA) ; and amino acids, and polymers thereof, such as peptides and proteins, constituting the machinery of a cell, by which many other molecules, such as carbohydrates and multimers thereof, lipids and lipid complexes, hormones, vitamins, co- factors, and so on are produced.
- Ribosomal proteins adhere to strands of nucleic acid when translating these in newly produced proteins.
- Newly produced proteins for example act as enzyme, by having affinity and thus by binding to its specific substrate. After enzymatic modification of the substrate the affinity or binding capacity for the resulting reaction product is in general less, and the reaction product is released.
- cytoplasmic receptor proteins act as subsequent transporting means, binding a product at one side and releasing it at another side of the cell, again based on affinity interaction.
- proteins interact with other molecules, such as peptides, co- factors, metal -ions, to form functional protein complexes, such as major or minor histo-compatibility complexes that comprise peptides that are presented to yet other receptor proteins recognizing the thus formed peptide- protein complex.
- Foreign antigens invading an organism get recognized and bound by antibodies formed by cells of said organism in mounting an immune response. Said antibodies can be detected in diagnostic assays because they have a specific affinity for the disease antigens in question.
- Absove examples all relate to interactions between molecules based on their mutual affinity. Such interactions are not necessarily only occurring between biological molecules only.
- Receptor proteins such as hormone receptors, can also have affinity for synthetic organic molecules, such as synthetic hormones.
- Synthetic nucleic acid analogues such as peptide nucleic acids (PNA) have been produced that mimic binding of DNA or RNA.
- Antibodies can bind to haptens, small, even inorganic molecules, for which said antibody has affinity.
- Synthetic compounds are known that influence biological molecule action, and thus life's processes, by affinity interaction.
- Current drug development programs focus mainly on the detection of molecules that can specifically interact somewhere in a cascade of molecular events seen with (patho) - physiological processes in the cell, and thus focus on molecules having specific affinity for the said molecular events .
- the mixture when desiring to purify a distinct protein from a mixture by affinity separation, the mixture can be mixed or contacted with a sorbent or carrier coated with antibodies that are specific for the desired protein, the antigen (see, e.g.: Molecular Cell Biology, Darnell, Lodish and Baltimore, Freeman and Company, 1990) . Only that protein binds to the antibody and is thus retained at the sorbent or carrier, any other proteins do not bind and can be washed off or be eluted.
- a suitable eluent such as an acetic acid solution is added to disrupt the antigen-antibody complex, so that a pure protein can be washed off or eluted from the sorbent or carrier.
- a suitable eluent such as an acetic acid solution
- beta-adrenergic receptor can be achieved by binding a potent receptor-binding antagonist such as alprenolol by chemically linking it to polystyrene beads.
- a potent receptor-binding antagonist such as alprenolol
- a crude, detergent solubilized preparation is passed through a column containing these beads . Only the receptor binds to the beads; the other proteins are washed through by excess fluid. On the addition of an excess alprenolol to the column, the bound receptor is displaced from the beads and eluted by competitive binding to the free alprenolol.
- Affinity separation is thus is a powerful technique for isolating and concentrating components of interest from a more or less complex mixture. It offers the possibility of separating substances from complex samples with a selectivity which cannot be achieved by other methods.
- This selectivity is derived from the use of a solid phase support comprising an affinity ligand, such as a specific nucleic acid (DNA, RNA or PNA) , a specific glycan, a native or synthetic proteinaceous binding molecule such as a (poly) peptide, a receptor, enzyme, a (synthetic) antibody molecule, a specific antigen or hapten, or any other specific binding molecule.
- an affinity ligand such as a specific nucleic acid (DNA, RNA or PNA) , a specific glycan, a native or synthetic proteinaceous binding molecule such as a (poly) peptide, a receptor, enzyme, a (synthetic) antibody molecule, a specific antigen or hapten, or
- a sample passed over or led through an affinity column separates into two bands or fractions.
- the second band containing only the desired compound or analyt, is bound by the ligand and thus retained.
- the type of solid phase support or sorbents used in these types of applications specific criteria have to be met . Not only has the support to be mechanically and physically stable and in general needs to be a hydrophilic solid phase support, but also other parameters have to be considered, such as particle size, pore-size distribution, available specific area and polymer flexibility to achieve high ligand accessibility. Non-specific adsorption and interaction should be avoided at all times.
- the solid phase support has preferably to be a rigid material .
- sorbents or packing materials and/or solid phase supports continue to be developed with improved chemical and mechanical stability and/or chromatographic performances.
- conditions have to be optimised for each application, some common criteria dictate the selection of the supports.
- they should be chemically and physically stable, and possess good mechanical strength to allow high flow rates. These conditions are in general met by inorganic sorbents such as silica or glass or metal oxides comprising for example alumina, zirconium or titanium.
- inorganic sorbents such as silica or glass or metal oxides comprising for example alumina, zirconium or titanium.
- they should not contain groups that bind the compounds of interest non- specifically, but should be easily derivatizable to allow the introduction of functional groups for interactive chromatographic applications.
- the inorganic sorbents show high non-specific binding or adsorption. Furthermore, their ability to withstand regeneration and cleaning procedures is also an important parameter. Furthermore, they should be produced with controllable size and pore size distribution and should be reproducible from batch to batch. Low cost, maximum throughput and high selectivity are important considerations.
- a wide variety of materials, including organic and inorganic polymers, have been used for the design of solid phase supports. New surface derivatization procedures have been introduced in order to control non-specific adsorption and to provide new ligands with enhance selectivity and resistance to hydrolysis. Packing materials can also be classified according to their structure . They can be divided into non- porous or porous.
- rigid, semi-rigid or soft packings are related to their mechanical strength, which depends strongly on their ability to shrink or swell in the presence of certain solvents.
- Soft gels exhibit poor mechanical stability and can withstand pressures up to 3-5 bar only.
- Semi-rigid materials can be operated under medium pressure (15-30 bar)
- rigid materials can be operated under high pressure (200-300 bar) and thus allow application in the traditional high performance liquid chromatographic techniques.
- a description of column packing materials or sorbents includes two aspects: the base support or core and a stationary phase or coating that is chemically or physically immobilised on the core and carries the necessary functions.
- a packing material generally comprises a base support (core or carrier) supporting the stationary phase which is in equilibrium with the mobile phase.
- the stationary phase might be the support itself or an interfacial layer or coating.
- Numerous packing materials are produced by linking the functional moieties onto the core.
- composite materials are obtained by coating a non-inert core particle with a polymeric layer prior to the introduction of functional groups.
- the base support plays a dominant role in the mechanical, chemical and thermal stability of packing materials.
- a coating for a packing material should be chemically resistant and should effectively shield the core from solvent degradation or non-specific interactions with the compound of interest.
- the first organic polymers to attract interest for packing materials were natural polysaccharides, including agarose, cellulose, cross-linked dextran and, to a lesser extent, cross-linked amylose and starch.
- organic materials are based on synthetic polymers, like the polyacrylamides, polyacrylates and polyvinyl polymers. Their main advantage is their pH stability. Furthermore, most of them are more resistant to pressure than polysaccharides. Disadvantages in comparison to inorganic materials are lower pressure tolerance, swelling changes that may occur in the presence of organic solvents, broader pore-size distributions and decreased efficiency.
- hydrophobic character of e.g. the polyvinyl polymers direct use in biochromatography is limited, due to, in most cases, undesirable non-specific interactions with the compound of interest, and surface modification must be used to increase their polarity. Undoubtedly, silica is the most widely used chromatographic material being available in a wide range of particle sizes and porosities.
- Silica is very stable under pressure and can easily be derivatized to introduce functional ligands.
- silica is unstable at mild alkaline pH values and dissolves drastically above pH 8.
- silanol-groups at the silica surface after silanisation due to not fully protected silanol-groups at the silica surface after silanisation, non-specific reactions occur between these deprotonated silanol groups and the basic parts of for instance biomolecules.
- Other rigid material inorganic sorbents (controlled pore) glass or metal oxides comprising for example alumina, zirconium or titanium can be used, however, due to a diversity of disadvantages in relation to silica their application is not as widespread.
- the invention provides a packing material comprising an anorganic sorbent, such as silica, controlled pore glass or, preferably, a metal oxide, such as alumina, zirconia, thoria or titania, or hydroxyapatite, for use in separation of molecules, such as by (immuno) affinity, by ion exchange, or by hydrofobic interaction separation, by chiral separation, or for example in reversed phase chromatography, wherein said sorbent has been provided with a polymer coating to prevent non-selective adsorption, which polymer has preferably been cross-linked and which preferably also has been provided with a spacer to provide maximum motional freedom and therefor the best adaptation towards adsorbing proteins or other molecules, said spacer comprising a coupling site.
- an anorganic sorbent such as silica, controlled pore glass or, preferably, a metal oxide, such as alumina, zirconia, thoria or titania, or hydroxyapati
- hydrophobic interaction chromatography is defined as a type of affinity chromatography involving the association of lipophilic regions of the component of interest and hydrophobic ligands (butyl, octyl and phenyl groups as well as pentyl , hexyl , dodecyl , palmityl and naphthoyl and trityl groups have been reported) immobilised on the support.
- the hydrocarbon regions which are responsible for the hydrophobic character are either aliphatic or aromatic or both and possess the common properties of excluding water and forming a hydrophobic association. Hydrophobic interactions are relatively strong and their strength is dependent on the nature of the molecule and can be influenced by salt concentration and by temperature.
- the adsorption of the component of interest is generally performed at high ionic strength (1-3 M) , while a decreasing salt gradient is used to elute the components from the column.
- Ionexchange chromatography uses supports in which electrically charged chemical groups are covalently attached. Interaction occurs between an isolate molecule carrying a charge (either positive or negative) and a sorbent carrying a charge opposite to that of the isolate. Ionexchange interactions are divided into cation (positively charged) and anion (negatively charged) .
- Anionic groups include strong acids such as sulphonates, sulphates and phosphates and weak acids such as carboxylates .
- Cationic groups are represented by tertiary amino groups (weak) and quarternary amino groups (strong) . All these chemical groups are attached to the support through a spacer by means of ether, alkylamine or amido bonds .
- An affinity sorbent for affinity chromatography is prepared by the attachment of a defined ligand on an inert matrix by means of a chemical reaction.
- the support must be essentially inert to avoid non-specific binding which decreases the level of selectivity and must have chemical groups available where ligands can be chemically attached after treatment with activating agents. These groups are frequently hydroxyl groups, amido, carboxyl or amino groups to adapt immobilisation chemistry.
- Ligand coupling reactions most frequently involve nucleophilic attack. The coupling reaction should preferably be chosen so that biological inactivation of the ligand is avoided or minimised.
- Adsorption chromatography can be best described by the polar interactions between the stationary phase and the functional groups on isolates.
- Polar interactions include hydrogen bonding, dipole/dipole, induced dipole/dipole, pi-pi and a variety of other interactions in which the distribution of electrons between individual atoms in the functional groups is unequal causing positive and negative polarity.
- Groups that exhibit these types of interactions typically include hydroxyls, amines, carbonyls , aromatic rings, sulfhydryls, double bonds and groups containing hetero-atoms such as oxygen, nitrogen, sulfur and phosphorus.
- Enantiomeric separations are for instance based upon the formation of inclusion complexes (cyclodextrins) , attractive interactions or dipole stacking, , hydrogen bonding and/or ⁇ - ⁇ interaction, hydrofobic interaction or diastereomeric metal complexes of isolate with the functional group of the stationary phase.
- Surface bonded stationary phases or sorbents according to the invention can be prepared by chemical modification or physical adsorption of polymers. Chemical modification can be achieved by linking functional groups directly to the surface leading to monolayer bonded phases. The most efficient shielding of surfaces is obtained with polymer layers.
- a suitable polymer is deposited and physically adsorbed on the sorbent, preferably a metal - oxide.
- the physical adsorption step is followed by cross-linking, either between polymer chains or between polymer and sorbent surface in order to increase the stability or adhesion of the coated layer.
- a particular point to consider is the size of the polymer with regard to the pore size of the metal oxide particle and the affinity of the polymer for the surface of the metal oxide in the adsorption solvent. Higher affinity promotes better adhesion of polymer onto the metal oxide surface and, in most cases, a more homogeneous coating is provided.
- the base support or core particles should be between 5 ⁇ m - 3 mm in diameter, have a pore diameter of between 5 - 400 nm, a specific surface area of between 100 - 500 m2/g, be able to withstand pressures up to 300 bar and pH between 2-12.
- the invention provides a sorbent wherein said polymer is hydrophilic.
- suitable (organic) polymer is adsorbed directly to the surface of the sorbent, which adsorption for example occurs through Lewis acid-base interactions, electrostatic attraction, van der aals forces and/or hydrogen bonding between the organic functional groups of the polymer and the surface of the inorganic polymer support material.
- Typical useful hydrophilic polymers are polyethyleneimine or derivatives thereof, ethylenediamines or derivaties thereof, 1 , 3-diamino-2 -hydroxypropane, diethylaminoethyl -modified dextrans and/or agaroses or derivatives thereof.
- Others can be selected from natural polymers such as polysaccharide, dextran, cellulose, alginate and agarose, and synthetic polymers such as polyacrylamide, poly (acrylic) acid, pol (methacrylic acid) and methyl , ethyl , propyl and butyl derivatives thereof, polystyrene and sulfonated derivatives thereof, amino- substituted polystyrenes, poly (4 -hydroxy styrene) , poly(vinyl alcohol), poly (ethylene oxide), polycarbonates, polyester, polyethylene, polypropylene, polybutylene, polyisobutylene, polyamides (such as nylon), poly (ethyleneglycol) , hydroxylated cellulose derivatives, poly (vinylacetate) , polymethacrylate and methyl, ethyl, propyl and butyl derivatives thereof, styrene-divinylbenzene, acrylamide-bisacrylamide, epoxy, polysulfone, polyethylene
- the invention provides a sorbent wherein said polymer at least comprises polyethyleneimine or another related hydrophilic polymers as indicated above, which can of course also be used as last layer over on of the other above mentioned polymers.
- said polymer at least comprises polyethyleneimine or another related hydrophilic polymers as indicated above, which can of course also be used as last layer over on of the other above mentioned polymers.
- it is provided to adjust the sorbent surface by coupling a polymeric layer onto the solid phase support by electrostatic attraction between the charged surface and the charged polymer, provided they carry opposite surface charges.
- Polymers which are suitable for this purpose are polyethyleneimine and for example dextran or agarose with dimethylaminoethyl groups which both carry positive charges that have been attached to the in general negatively charged metal-oxide surface.
- the invention provides a polymer coated metal oxide sorbent wherein said metal oxide comprises alumina.
- Metal sorbent as provided by the invention have distinct advantages. Metal oxides such as alumina, titania or zirconia have a chemical stability that is in general much higher than that of silica. For instance, alumina is chemically more resistant than silica and dissolves only above pH > 12 and under pH ⁇ 3.
- alumina a class of compounds with the composition Al 2 0 3 .nH 2 0, where n ranges from 0 to 3 is meant.
- Porous active alumina is well-known in the art and for instance employed as adsorbent and catalyst, and although as polar as silica, its surface chemistry is somewhat different due to the presence of Lewis acid and Lewis basic sites which is reflected by its chromatographic retention behaviour.
- An aqueous suspension of alumina has a pH of approximately 9 and, as a result, possesses cation exchange properties.
- This basic alumina can be converted to a 'neutral' or further to an 'acidic' alumina which then act as anion exchanger.
- Alumina preferentially retains organic compounds with carbon- carbon double bonds.
- alumina is therefore frequently used as straight phase solid phase material .
- Alumina can be characterised as a support with high mechanical and physical stability. Thanks to the fact that alumina is relatively cheap and produced in large quantities, the material is frequently used for purification purposes on large scale.
- affinity separation with alumina-based sorbents has never been provided.
- An advantage of alumina above silica is its pH stability in a much wider range, a property which is (sometimes) necessary for (immuno) affinity chromatographical applications.
- the invention also provides an anorganic sorbent, such as a silica, glass or metal oxide sorbent, having been provided with a functional moiety to allow coupling of said sorbent with an affinity ligand.
- One of the main criteria for selecting a suitable support for (immuno) affinity chromatographic applications is that the ligand is immobilised is such a way that it retains most of its biological properties and that the support itself does not contribute to non-selective absorption of the analyt of interest. Due to the properties of most rigid materials (polystyrene, as well as metal oxides), it must again be emphasised that, due to possible non-selective interactions, these materials cannot directly be used for (immuno) affinity chromatographic applications. Therefore, adjusting the surface of these materials in order to change their physical and chemical properties is in general needed prior to coupling of the ligand of interest.
- Activation can be defined as the process of chemically modifying a sorbent so that the product of the process, the functional moiety, will react to form a covalent bond with a ligand of choice.
- the method selected for activation of a sorbent is preferably compatible with both the ligand and the sorbent. Secondly, the method of activation is chosen such that high yields and rapid coupling is achieved; ligand leakage is minimised; unsuccessful coupling does not lead to nonspecific absorption effects; and the activation does not alter the porosity or other properties of the matrix.
- the invention provides a sorbent wherein to prevent leaching of the adsorbed polymer layer from the support and to produce a solvent and pH resistant support, the stability of the stationary phase obtained is increased by cross-linking of the adjacent organic groups of the adsorbed polymer.
- a multifunctional crosslinking reagent comprising reactive groups which subsequently can be further derivatised using conventional techniques to produce chromatography materials useful for conducting (immuno) affinity, ion exchange, hydrophobic interaction and other forms of chromatographic separations may be used.
- crosslinking can for example be achieved with compounds with the following general formula :
- a and B are functional groups on a crosslinker C that reacts with the functional groups of the adsorbed polymer and may be same of different, while m and n may vary from 1 to several hundred.
- Modification of the properties of the stationary phase is performed by the organic moieties D and E.
- the number of D and E ligands represented by o and p may vary from zero to several hundred in the crosslinking molecule.
- Crosslinking is preferably performed with a multifunctional peroxide (1 , 2-ethanediol diglycidyl ether, 1,4 -butanediol diglycidyl ether, 1,3 diglycidylglycerol or triglycidylglycerol) , a multifunctional anhydride (such as polyacrylic anhydride), an alkyl bromide (such as 1,3- dibromopropane) or a nitro alcohol (such as 2-methyl-2-nitro- 1, 3-propanediol) .
- a multifunctional peroxide (1 , 2-ethanediol diglycidyl ether, 1,4 -butanediol diglycidyl ether, 1,3 diglycidylglycerol or triglycidylglycerol
- a multifunctional anhydride such as polyacrylic anhydride
- an alkyl bromide such as 1,3- dibromopropane
- site-directed chemistry can be built on the end of the spacer and its length can aid in reaching the appropriate functionality on the ligand of interest.
- Most spacers are built from individual molecules no more than 10 atoms in length. They have appropriate coupling functionalities or coupling sites on either end and an overall hydrophilic character.
- Suitable spacer molecules as for example provided here are diaminodipropylamine (3,3'- iminobispropylamine) , 1 , 6-diaminehexane, 6-aminocaproic acid, succinic acid, 1 , 3-diamino-2-propanol , ethylenediamine, hydrophilic amino acids (such as glycine, poly-L-glutamic acid, alanine, poly-L-aspartic acid, beta-alanine, cysteine, poly-L-lysine and homocysteine) and aminated epoxides (such as epichlorohydrin and 1, 4 -butanediol diglycidyl ether).
- cyclic anhydrides such as succinic anhydride and glutaric anhydride, containing a 4- and 5-carbon chain
- Spacer molecules useful in these various types of separation typically are attached through the residual reactive groups accessible on the crosslinked coating using chemistries well known, and may for example be further to provided them with functional moieties by treatment with : 1) polyethers of various lengths to produce swellable hydrophilic tentacles extending from the substrate's surface; 2) alkanols to produce ether linked hydrocarbons of various lengths ranging, for example, from C4 to C20; 3) polyethyleneimine to produce a cationic resin (anion exchanger) which itself may be derivatised further; 4) tertiary amines (e.g.
- affinity ligands such as antibodies, (receptor) proteins, enzymes and other biological and synthetic molecules may be immunochemically, electrostatically or covalently coupled to the coatings using procedures known per se .
- the invention furthermore provides an anorganic sorbent coated with a polymer according to the invention wherein said functional moiety comprises for example hydrazide or aldehyde.
- An hydrazide activated support as provided by the invention is preferably used to immobilise a variety of glycoproteins .
- Hydrazide immobilisation chemistry permits the coupling of aldehyde- or ketone-containing ligands through the formation of stable hydrazone linkages. Since the hydrazone bonds are stable without the use of reductants, sensitive proteins are more likely to retain activity after immobilisation. Secondly, it was found that the immobilisation of antibodies to a hydrazide group containing sorbent revealed the highest retention of antigen binding activity.
- Site-directed immobilisation of antibodies as provided by the invention in which the antibody is coupled in such a way that the molecule can be oriented on the support so its bivalent binding potential for antigen can be realised fully, is allowed by hydrazide activation chemistry, which is especially useful in this regard.
- the method takes advantage of the carbohydrate chains coming off the heavy chains in the CH2 domain. Mild oxidation of the sugar residues of the antibody using sodium periodate will generate formyl groups which then can be used to immobilise the antibody specifically through these modified carbohydrate residues. Generally, this method results in the coupling of intact antibody molecules and usually gives the highest yield of antigen binding site activity.
- At least two methods are available to make a hydrazide- containing support.
- an aldehyde- containing sorbent is generated by oxidation with sodium periodate. This intermediate is then reacted with adipic dihydrazide to produce the active hydrazide-containing support.
- This procedure in general results in a sorbent that is highly cross-linked when the adipic dihydrazide is coupled.
- a spacer arm is initially coupled to the matrix, leaving a terminal carboxyl group.
- Adipic dihydrazide is then coupled to this sorbent using the EDC conjugation chemistry.
- This spacer provides greater steric accommodation needed for antibodies and is relatively hydrophilic to prevent non-selective adsorption. This latter procedure is preferred for the activation of the modified polymer coated sorbent such as polymer coated alumina.
- an aldehyde activated support is provided. Similar chemistries can be used, however, if in a preferred embodiment glycidol is coupled to the material followed by mild oxidation by means of sodium periodate to give the aldehyde activated sorbents.
- ligand coupling is relatively simple and in the presence of sodium cyanoborohydride stable amide bonds are formed between the sorbent and the ligand of interest.
- polymer coated sorbents such as the metal oxide sorbents as provided by the invention having good pH stability as well as adequate mechanical and physical stability and large availability against low costs, and the possibility to circumvent possible non-selective interaction by the adsorption of a polymer such as polyethyleneimine, further strategies are provided to activate this modified sorbent in order to couple ligands of interest (antibodies, enzymes, receptors, proteins, etc.) .
- the invention also provides a method for providing a sorbent having been provided with a polymer coating to prevent non- selective adsorption with a desired coupling capacity for an affinity ligand comprising providing said sorbent with a functional moiety to allow coupling of said sorbent with an affinity ligand.
- the invention provides a method to provide a polymer coated silica sorbent with a functional moiety which comprises for example hydrazide or aldehyde, linked to said sorbent as described above.
- said coated silica sorbent is coated with a hydrophilic polymer which comprises polyethyleneimine.
- the invention provides polymer coated sorbents having been provided with an affinity ligand, for example wherein said ligand comprises a protein or a glycoprotein.
- an affinity ligand for example wherein said ligand comprises a protein or a glycoprotein.
- Such polymer coated sorbents, having been provided with a functional moiety to couple an affinity ligand, are particularly useful to couple for example an antibody.
- Such sorbents as provided by the invention are preferably used as packing material for a molecule separation unit, such as a chromatography column for, for example, high-performance liquid chromatography (HPLC) .
- HPLC high-performance liquid chromatography
- the invention also provides a molecule separation unit comprising a sorbent according to the invention, such as a column packed with a polymer coated sorbent .
- a molecule separation unit as provided by the invention in particular suitable for large scale separation, for example comprises a fluidised bed wherein for instance fermentation broth or another medium is fed through a floating bed which will not or only little clog; after the molecule of interest is adsorbed and the bed is saturated, the molecule of interest can be efficiently desorbed and the bed can be reused for another round of Fluidized Bed Chromatography.
- the invention provides a chromatography column for for example Column Chromatography or Radial Flow Chromatography (Radial Flow columns are eluted in radial direction) .
- Such units are preferably used in a method as provided by the invention (see also the detailed description) for determining the presence of a substance in a sample comprising submitting said sample to a molecule separation unit according to the invention, separating at least part of said substance from said sample by at least partly retaining it in said unit, further comprising eluting said substance from said unit and determining the presence of said separated substance in the eluted fraction, preferably further comprising separating at least part of said substance from said sample by at least partly retaining said substance in said unit.
- said desired substance is retained by affinity of said substance to an affinity ligand, the method further comprising eluting said retained substance from said unit .
- the invention is further explained in the detailed description without limiting the invention thereto.
- a model HOB liquid chromatograph equipped with a model 163 variable UV-VIS detector (Beckman) or a model DECADE electrochemical detector (Antec Leyden, Leiden) was used. Injection was carried out by means of a model 210A Sample Injection Valve (Beckman, Leiden) . The peaks were monitored by means of a model Chrom-Jet integrator (Interscience, Breda). The (immuno) affinity column was coupled on- and off-line with the analytical system by means of a Rheodyne two-position six-way valve (Bester, Amsterdam) . See figure 1 for a possible instrumental set up.
- polyacrylic anhydride Prior to modification of the alumina, polyacrylic anhydride was synthesised by weighing 10 gram of polyacrylic acid into a 100 mL flask and placing this in a oil batch at 180 °C for 3 hours. A stream of nitrogen flushed the surface of the solid during heating.
- Alumina (4 g) was suspended in 90 mL methanol containing 6 mL of PEI-18 solution. The suspension was stirred at 30 °C for 4 hours. The PEI-coated alumina was filtrated on a G4 glass filter, washed with dry N,N-dimethylformamide and dried under vacuum. The PEI-coated alumina was cross-linked by suspending the material obtained in 25 mL of dry N,N-dimethylformamide, containing 1,5 mL of dry N,N-diisopropylamine and 500 mg of polyacrylic anhydride. The reaction was completed by stirring the suspension overnight at 60 C. The resulting media was filtrated on a G4 glass filter and washed with methanol, triethylamine and N, N-dimethylformamide .
- the PEI-coated material was suspended in 10 mL of N,N- dimethylformamide containing 1 g of N,N-carbonyl diimidazole. The reaction was completed by stirring the suspension for 1 hour at 30 °C. The product obtained was isolated on a G4 glass filter and was washed with N, N-dimethylformamide and acetone .
- Diaminodipropylamine (1 g) was dissolved in 5 mL of acetone. Towards this solution the product obtained under A. was added and the suspension obtained was allowed to react for 3 hours at room temperature by stirring. The product was isolated on a G4 glass filter and was washed with acetone, water, 1 M NaCI and water.
- the product obtained under B. was suspended in 4 mL of water containing 0,5 g of succinic anhydride. The reaction was allowed to complete by stirring for 1 hour at 30 °C. The product obtained was isolated on a G4 glass filter and was washed with water, 1 M NaCI and water.
- the PEI-coated material was suspended in 10 mL of N,N- dimethylformamide containing 1 g of N,N-carbonyl diimidazole, The reaction was completed by stirring the suspension for 1 hour at 30 °C. The product obtained was isolated on a G4 glass filter and was washed with N, N-dimethylformamide and acetone . Introducing a spacer (diaminodipropylamine)
- Diaminodipropylamine (1 g) was dissolved in 5 mL of acetone. Towards this solution the product obtained under A. was added and the suspension obtained was allowed to react for 3 hours at room temperature by stirring. The product was isolated on a G4 glass filter and was washed with acetone, water, 1 M NaCI , water and 1 N NaOH.
- the product obtained under B. was suspended in 4 mL of 1,0 N NaOH containing 0,4 mL of glycidol and 10 mg of sodium borohydride. The reaction was allowed to complete by stirring overnight at room temperature. The product obtained was isolated on a G4 glass filter and was washed with water, 1 M NaCI and water.
- the product obtained under C . was suspended in 4 mL of 0 , 2 M sodium metaperiodate. The reaction was allowed to complete by stirring for 90 minutes at room temperature. The product obtained was isolated on a G4 glass filter and was extensively washed with water.
- Anti-estradiol 200 ⁇ g was dissolved in 500 ⁇ L 0,1 M phosphate buffer pH 7,0. Towards this solution 10 mg of sodium periodate was added and dissolved by gently mixing. The reaction was allowed to stand for 30 minutes at 4 °C in the dark. The solution was desalted by ultrafiltration at 5000g for 30 minutes at 4 °C with a Centrisart C30 filter. The pellet obtained was dissolved in 1 mL of 0 , 1 M phosphate buffer pH 7,0 and was added to 1,4 g of HY actived alumina washed prior with 0,1 N phosphate buffer pH 7,0. The reaction was allowed to complete by stirring overnight at room temperature. The anti-estradiol coupled media was finally washed with 0,1 M phosphate buffer pH 7,0.
- Anti-vitamin B12 (150 ⁇ g) was dissolved in 500 ⁇ L 0,1 M phosphate buffer pH 7,0. Towards this solution 10 mg of sodium periodate was added and dissolved by gently mixing. The reaction was allowed to stand for 30 minutes at 4 °C in the dark. The solution was desalted by ultrafiltration at 5000g for 30 minutes at 4 °C with a Centrisart C30 filter. The pellet obtained was dissolved in 1 mL of 0 , 1 M phosphate buffer pH 7,0 and was added to 1,4 g of HY actived alumina washed prior with 0,1 N phosphate buffer pH 7,0. The reaction was allowed to complete by stirring overnight at room temperature. The anti-vitamin B12 coupled media was finally washed with 0,1 M phosphate buffer pH 7,0.
- Glucose oxidase (1 mg) was dissolved in 1 mL of 0,1 M phosphate buffer pH 7,0. Towards this solution 1,4 gram of washed prior with 0,1 M phosphate buffer pH 7,0 aldehyde activated alumina was added and 10 mg of sodium cyanoborohydride. The reaction was allowed to complete by stirring overnight at room temperature. The glucose oxidase coupled media was finally washed with 0,1 M phosphate buffer pH 7,0. Coupling of hER receptor
- hER Human Estrogen Receptor
- the supports obtained were packed in 50 x 4,6 mm empty PEEK columns at a flow rate of 10 mL/min with water as eluens . Suspensions were made in water, whereas packing was performed according to the procedures described by Boehringer Mannheim for packing of media with the Self Packing Device.
- the media was tested for non-selective adsorption of apolar components (here estradiol or testosteron were used and polar components (vitamin B12) .
- Batch experiments were carried out by adding standard solutions in 0,1 M phosphate buffer pH 7,0 to modified alumina. After incubation, the upper standing liquid was analysed by RP-HPLC on the content of the standard added. By comparing the results with those of a direct injection of the standard solution, it was found that no non- selective adsorption of the above mentioned compounds was observed. Based on these findings, it was decided to proceed with the activation of the mofidied alumina.
- the modified alumina For the activation of the modified alumina, two different procedures were developed; one for the site-directed immobilisation of antibodies (the hydrazide activated alumina) and one for the immobilisation of for instance enzymes, proteins, receptors etc. (the aldehyde activated alumina) .
- the hydrazide activated alumina Experiments with covalent coupling of antibodies or other proteins directly to the surface of N,N carbonyl diimizole activated coated alumina provided sorbents with coated ligand.
- spacers provided higher ligand accessibility, providing the sorbents with high capacities to bind ligands of interest.
- both activated media was again tested for non-selective adsorption of estradiol, testosterone, vitamin B12 respectively estradiol.
- batch experiments as mentioned above as well as blank columns were tested for non-selective adsorption.
- non-selective adsorption of the analytes was observed.
- the repeatability expressed as the relative standard deviation in the peak heights measured, was found to be 4%. Linearity of the method was found to be up to 2000 ng/mL of estradiol. Selectivity of the assay was determined by analysing a serum sample containing a variety of hormones . Although the immobilised antibody did show cross-reactivity (see figure 3) , estradiol could be determined accurately thanks to the additional separation by means of RP-HPLC. Regarding the stability of the immunoaffinity column, the column was stored at 4 °C and tested again for its capacity after 6 months of storage .
- vitamin B12 was quantitatively eluted by means of 30% v/v methanol and 70%v/v water containing 500 ⁇ L of concentrated HCL + 150 mM NaCI per L water.
- the precision of the method was determined by analysing a standard solution of 7,96 ⁇ g/mL of vitamin B12 six times. The repeatability, expressed as the relative standard deviation in the peak heights measured, was found to be 4%. Linearity of the method was found to be up to 10 mg/L of vitamin B12. At a concentration of 20 mg/L and 40 mg/L breakthrough of vitamin B12 was observed.
- the accuracy and/or selectivity of the assay was determined by analysing two fermentation broth samples. By comparing the results with the theoretically values, it was concluded that the method is accurate and selective for the determination of vitamin B12 in fermentation broth. An example of a chromatogram together with the chromatographic conditions is demonstrated in figure 4.
- Glucose oxidase converts glucose in gluconolactone and H202.
- the hydrogenperoxide generated in this reaction can electrochemically be determined on a platinum electrode which is polarised at +500 mV vs. an Ag/AgCl electrode.
- a flow rate of 0,5 mL/min standard solutions of glucose were injected onto the column and it was found that up to 50 mM glucose, determination of glucose was possible via this way. From these results it was concluded that biomolecules could be coupled to activated metal oxide, e.g. aluminium, without loosing their biological activity.
- human Estrogen Receptor (hER) was coupled to the aldehyde activated affinity media. It is wellknown that microcontaminants in the environment can initiate several biological effects, for instance after binding to receptors. At the moment, the estradiol receptor gains an increased interest in environmental research and health control . This receptor binds estradiol and regulates the concentration of estradiol in the blood of organisms. Estradiol is a female hormone and plays an important role in the reproduction of mammals as well as fishes. More and more studies points out the presence of microcontaminants in the environment which exhibit affinity with this receptor and affecting in a negative way the reproduction of several species in the environment.
- xeno-estrogenic compounds World-wide the interest in these so-called xeno-estrogenic compounds increases but only a limited amount of tests are available to screen and identify compounds for their estrogenic activity.
- human Estrogen Receptor By coupling human Estrogen Receptor to a solid phase support, analytes of interest can be selectively isolated from the matrix by means of their biological activity. Compounds with xeno-estrogenic activity will be captured by the hER affinity column, whereas compounds which do not show xeno-estrogenic activity will not be captured by the hER affinity column.
- quantitative analysis of the compounds captured can be carried out by means of RP- HPLC. So, in order to develop such an assay, the hER affinity media produced as described above was packed and tested for its capacity.
- Coating of metal oxides the conventional way via organosilane chemistry does not lead to the required characteristics; the materials maintain their character and undesirable non- selective adsorption remains.
- Coating with hydrophilic polymers via electrostatic attraction alters the characteristics of the supports significantly; no non- selective adsorption of nonpolar or polar compounds such as testosterone or estradiol respectively vitamin B12 was observed.
- metal oxides alumina as solid phase support for the production of (immuno) affinity columns which can be used in combination with conventional HPLC.
- the production of these materials is relatively cheap compared to polymer based materials and has the advantage of conventional high pressure liquid chromatography solid phase materials such as resisting high pressures and organic solvents.
- affinity ligands such as antibodies
- site-directed coupling is preferred.
- the use of a spacer is required.
- Using the spacer diaminodipropylamine in combination with succinic anhydride does not lead to non-selective adsorption of apolar or polar compounds like estradiol or testosterone respectively vitamin B12.
- Immobilisation through site- directed immobilisation by activation the support via adipic dihydrazide demonstrated to give good results.
- activation through bonding via Protein A or G e.g. coupled as ligand to aldehyde activated alumina is provided.
- Packing materials for other modes of chromatography are provided likewise, e.g. by coating a particle with a hydrophilic polymer, crosslinking, introducing a spacer followed by coupling of a functional moiety.
- ion exchange materials are provided by covalently coupling a weak cation, e.g. sulfanilic acid, respectively a strong cation, e.g. benzeensulfonic acid and quaternairy ammonium salt.
- a weak cation e.g. sulfanilic acid
- a strong cation e.g. benzeensulfonic acid and quaternairy ammonium salt.
- Figure 1 Schematic presentation of the instrumental set-up
- the serum sample contains besides estradiol, estriol, cortisol, aldosterone, progesterone, testosterone and 17- hydroxyprogesterone .
- Solvent A 0,01 M phosphate buffer pH 7 , 0
- Solvent B 30%v/v methanol and 70%v/v water containing 500 ⁇ L concentrated HCL per Litre + 150 mM NaCI
- Figure 5 Analysis of a standard solution of ⁇ -oestradiol (peak 1) after being capture and eluted by the hER-affinity column .
- Solvent A 0,01 M phosphate buffer pH 7 , 0 Solvent B : 25%v/v 6 M KSCN, 50%v/v solvent A and methanol Solvent C water Solvent D 65%v/v methanol Flow 0 , 5 mL/min Injection 50 ⁇ L Detection UV-VIS at 280 nm
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
L'invention concerne le domaine de la séparation de molécules, en particulier de biomolécules, contenues dans un milieu. L'invention concerne un sorbant servant à séparer les molécules, contenant une couche constituée d'un polymère, de préférence réticulé, (servant à empêcher une adsorption non sélective), comportant de préférence une molécule servant de bras écarteur et/ou une fraction fonctionnelle pour permettre le couplage d'un ligand d'affinité.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2000/000078 WO2001058561A1 (fr) | 2000-02-09 | 2000-02-09 | Materiau de garnissage pour la separation de biomolecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1255603A1 true EP1255603A1 (fr) | 2002-11-13 |
Family
ID=19760671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00904138A Withdrawn EP1255603A1 (fr) | 2000-02-09 | 2000-02-09 | Materiau de garnissage pour la separation de biomolecules |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1255603A1 (fr) |
| AU (1) | AU2000225808A1 (fr) |
| WO (1) | WO2001058561A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008506961A (ja) | 2004-07-19 | 2008-03-06 | グレイス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト | 装置構成要素および被検体の存在を検出するための装置構成要素の使用 |
| EP2090361A1 (fr) * | 2008-02-14 | 2009-08-19 | RESQ Lab B.V. | Résine de chromatographie améliorée et procédés et dispositifs correspondants |
| EP2570182A1 (fr) * | 2011-09-15 | 2013-03-20 | InstrAction GmbH | Sorbant comportant à sa surface un résidu aliphatique cationique ou protonisable pour la purification de molécules organiques |
| US11083820B2 (en) | 2013-01-21 | 2021-08-10 | Council Of Scientific & Industrial Research | Elastic macro porous scaffold and a process for the preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56115727A (en) * | 1980-02-19 | 1981-09-11 | Kuraray Co Ltd | Carrier for immobilizing physiologically active substance |
| CA1320718C (fr) * | 1987-06-08 | 1993-07-27 | Richard Frederick Hammen | Materiel chromatographique |
| DK0423938T3 (da) * | 1989-09-29 | 1994-03-28 | Rohm & Haas | Ligandholdigt medium til kromatografisk adskillelse, fremgangsmåde til fremstilling af mediet og anvendelse af mediet til isolering af syntetiske eller naturlige molekyler fra en fluidumblanding |
| ES2116977T3 (es) * | 1990-05-11 | 1998-08-01 | Microprobe Corp | Soportes solidos para ensayos de hibridacion de acidos nucleicos y metodos para inmovilizar oligonucleotidos de modo covalente. |
| US5906747A (en) * | 1995-11-13 | 1999-05-25 | Biosepra Inc. | Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates |
| US5914182A (en) * | 1996-06-03 | 1999-06-22 | Gore Hybrid Technologies, Inc. | Materials and methods for the immobilization of bioactive species onto polymeric substrates |
-
2000
- 2000-02-09 AU AU2000225808A patent/AU2000225808A1/en not_active Abandoned
- 2000-02-09 EP EP00904138A patent/EP1255603A1/fr not_active Withdrawn
- 2000-02-09 WO PCT/NL2000/000078 patent/WO2001058561A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0158561A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2000225808A1 (en) | 2001-08-20 |
| WO2001058561A1 (fr) | 2001-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mallik et al. | Affinity monolith chromatography | |
| US20050029196A1 (en) | Packing materials for separation of biomolecules | |
| CA1320718C (fr) | Materiel chromatographique | |
| US6610630B2 (en) | Chromatography adsorbents utilizing mercapto heterocyclic ligands | |
| Guo et al. | Chitosan beads as molecularly imprinted polymer matrix for selective separation of proteins | |
| EP1974215B1 (fr) | Matrices de chromatographie d'affinite et procedes de fabrication et d'utilisation correspondants | |
| Mallik et al. | High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns | |
| Potter et al. | Porous polymer monoliths for extraction: Diverse applications and platforms | |
| US7144743B2 (en) | Preparation and use of mixed mode solid substrates for chromatography adsorbents and biochip arrays | |
| JP5109003B2 (ja) | 刺激応答型アフィニティクロマトグラフィー材料等の分離材料および分離精製方法 | |
| US5559039A (en) | Method of using liquid column packing materials | |
| JP5826180B2 (ja) | 分離マトリックス | |
| Carlsson et al. | 10 Affinity Chromatography | |
| EP2254696B1 (fr) | Résine chromatographique améliorée et procédés et dispositifs s'y rapportant | |
| US6664305B2 (en) | Chromatography material and a process of manufacturing that material | |
| Gunasena et al. | Organic monoliths for hydrophilic interaction electrochromatography/chromatography and immunoaffinity chromatography | |
| Rhemrev-Boom et al. | (Immuno) affinity chromatography: a versatile tool for fast and selective purification, concentration, isolation and analysis | |
| WO2001058561A1 (fr) | Materiau de garnissage pour la separation de biomolecules | |
| Turková | Bioaffinity chromatography | |
| EP0403700B1 (fr) | Matrices de polyéthylène-imine pour chromatographie d'affinité | |
| WO2004100887A2 (fr) | Surfaces d'extraction en phase solide tridimensionnelles | |
| Turkova | Affinity chromatography | |
| Varilova et al. | Separation media in affinity chromatography of proteins-A critical review | |
| Morgan et al. | Polyvinyl alcohol‐coated perfluorocarbon supports for metal chelating affinity separation of a monoclonal antibody | |
| Turková | Academy of Sciences of the Czech Republic, Prague, and University |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020902 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050830 |